Compositions targeting the interaction domain between p27KiP1 and Brk and methods of use thereof to inhibit p27 Y phosphorylation and cdk4 activity
Abstract:
Compositions and methods for the treatment of malignancy are disclosed.
Information query
Patent Agency Ranking
0/0